Irit Arbel insider trades
Open-market stock purchases and sales by Irit Arbel, Director at Brainstorm Cell Therapeutics Inc, from SEC Form 4 filings since Aug 31, 2009.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -73%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 26, 2026 | BCLI Brainstorm Cell Therapeutics Inc | Bought (not open market) | — |